CVS Health's Aetna is simplifying the prior authorization process for cancer patients. Instead of requiring separate approvals for each component of cancer care — think chemo, radiation, MRI scans, and immunotherapy — Aetna will bundle it all into a single upfront authorization. Providers just need to submit documentation confirming a patient is undergoing cancer treatment, and they're cleared to proceed. The rollout begins for Medicaid members in eight states (as of September 1) and expands to all private and Medicare Advantage plans in the first half of 2027.

The change is part of a broader industry push to reduce administrative friction. Aetna's COO Katerina Guerraz pointed to oncology as the priority given how heavily cancer treatment relies on repeated radiology scans — a major driver of repeated authorization requests. Aetna also plans to eventually extend the bundled model to musculoskeletal conditions like knee and hip issues.

By the Numbers:

• 4 — average prior authorizations submitted per Aetna cancer patient during treatment
• 74% of providers flagged administrative burden as a top clinical challenge
• 31% cited prior authorizations specifically as the biggest factor
• UnitedHealthcare pledged to cut ~30% of prior auth requirements; Humana pledged 33% for outpatient services

Why it matters: For oncologists and their patients, fewer authorization hurdles means faster access to life-saving treatments and less time lost to paperwork — a meaningful shift as cancer rates continue to climb.